Concepts (57)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity, Morbid | 2 | 2022 | 98 | 0.830 |
Why?
|
| Laparoscopy | 3 | 2022 | 491 | 0.780 |
Why?
|
| Gastroplasty | 1 | 2021 | 16 | 0.730 |
Why?
|
| Gastric Bypass | 1 | 2021 | 76 | 0.700 |
Why?
|
| Specialties, Surgical | 1 | 2017 | 48 | 0.530 |
Why?
|
| Perioperative Care | 1 | 2017 | 85 | 0.520 |
Why?
|
| Hernia, Inguinal | 2 | 2021 | 42 | 0.350 |
Why?
|
| Anus Neoplasms | 2 | 2019 | 23 | 0.300 |
Why?
|
| Robotic Surgical Procedures | 2 | 2021 | 157 | 0.290 |
Why?
|
| Gastrectomy | 2 | 2022 | 40 | 0.230 |
Why?
|
| Esophagitis | 1 | 2022 | 9 | 0.190 |
Why?
|
| Opiate Alkaloids | 1 | 2021 | 1 | 0.190 |
Why?
|
| Hernia, Hiatal | 1 | 2022 | 28 | 0.180 |
Why?
|
| Gastroesophageal Reflux | 1 | 2022 | 92 | 0.180 |
Why?
|
| Reoperation | 1 | 2021 | 289 | 0.170 |
Why?
|
| Case-Control Studies | 1 | 2021 | 1121 | 0.150 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 111 | 0.140 |
Why?
|
| Length of Stay | 2 | 2021 | 811 | 0.140 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2018 | 91 | 0.140 |
Why?
|
| Dendritic Cell Sarcoma, Interdigitating | 1 | 2017 | 1 | 0.140 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2019 | 257 | 0.130 |
Why?
|
| Clinical Protocols | 1 | 2017 | 139 | 0.130 |
Why?
|
| Rectal Neoplasms | 1 | 2017 | 104 | 0.120 |
Why?
|
| Recovery of Function | 1 | 2017 | 287 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2018 | 866 | 0.120 |
Why?
|
| Melanoma | 1 | 2018 | 331 | 0.110 |
Why?
|
| Treatment Outcome | 2 | 2021 | 5649 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2017 | 430 | 0.100 |
Why?
|
| Quality Improvement | 1 | 2017 | 442 | 0.100 |
Why?
|
| Retrospective Studies | 2 | 2021 | 6624 | 0.100 |
Why?
|
| Herniorrhaphy | 2 | 2021 | 70 | 0.090 |
Why?
|
| Humans | 8 | 2022 | 63281 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2017 | 1303 | 0.080 |
Why?
|
| Survival Rate | 2 | 2019 | 850 | 0.060 |
Why?
|
| Anesthesia, Local | 1 | 2021 | 20 | 0.050 |
Why?
|
| Bupivacaine | 1 | 2021 | 35 | 0.050 |
Why?
|
| Narcotics | 1 | 2021 | 58 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2021 | 138 | 0.050 |
Why?
|
| Liposomes | 1 | 2021 | 107 | 0.040 |
Why?
|
| Anesthetics, Local | 1 | 2021 | 71 | 0.040 |
Why?
|
| Surgical Mesh | 1 | 2021 | 60 | 0.040 |
Why?
|
| Operative Time | 1 | 2021 | 92 | 0.040 |
Why?
|
| Analgesics | 1 | 2021 | 102 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2021 | 163 | 0.040 |
Why?
|
| Cost-Benefit Analysis | 1 | 2021 | 311 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2019 | 75 | 0.040 |
Why?
|
| Chemoradiotherapy | 1 | 2019 | 66 | 0.040 |
Why?
|
| Male | 4 | 2022 | 29804 | 0.040 |
Why?
|
| Rectum | 1 | 2017 | 89 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 536 | 0.030 |
Why?
|
| Prognosis | 1 | 2018 | 1750 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 2460 | 0.020 |
Why?
|
| Aged | 2 | 2019 | 14385 | 0.020 |
Why?
|
| Middle Aged | 2 | 2019 | 17541 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 5443 | 0.020 |
Why?
|
| Young Adult | 1 | 2017 | 4683 | 0.020 |
Why?
|
| Female | 2 | 2019 | 32777 | 0.020 |
Why?
|